financetom
Business
financetom
/
Business
/
Molina Healthcare lowers annual profit forecast on medical cost pressures
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Molina Healthcare lowers annual profit forecast on medical cost pressures
Jul 7, 2025 3:55 AM

July 7 (Reuters) - Molina Healthcare ( MOH ) on Monday

lowered its annual adjusted profit forecast due to medical cost

pressures.

The company now sees adjusted profit per share to be between

$21.50 and $22.50, compared with at least $24.50 per share

expected previously.

(Reporting by Sriparna Roy in Bengaluru; Editing by Shinjini

Ganguli)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Market Chatter: Boeing Attracts Aviation, Private Equity Suitors in Potential Jeppesen Sale
Update: Market Chatter: Boeing Attracts Aviation, Private Equity Suitors in Potential Jeppesen Sale
Jan 27, 2025
05:02 AM EST, 01/27/2025 (MT Newswires) -- (Updates with GE Aerospace's response in the final paragraph.) Boeing's ( BA ) possible sale of its Jeppesen navigation unit is drawing interest from both aviation and private equity firms ahead of a deadline next week for first-round bids, Bloomberg reported Friday, citing people familiar with the matter. RTX (RTX), GE Aerospace (GE),...
Spotify Technology Signs Multi-Year Recorded Music, Music Publishing Deals With Universal Music Group
Spotify Technology Signs Multi-Year Recorded Music, Music Publishing Deals With Universal Music Group
Jan 27, 2025
04:50 AM EST, 01/27/2025 (MT Newswires) -- Spotify Technology ( SPOT ) and Universal Music Group said Sunday that they signed new, multi-year agreements to collaborate on recorded music and music publishing. The companies said their collaboration aims to advance streaming innovation and feature new offers, subscription tiers, music bundles, and non-music content. The agreements also cover a direct license...
Sarepta Therapeutics Says Phase 3 Study of Potential Muscular Dystrophy Drug Shows 'Positive' Results
Sarepta Therapeutics Says Phase 3 Study of Potential Muscular Dystrophy Drug Shows 'Positive' Results
Jan 27, 2025
04:28 AM EST, 01/27/2025 (MT Newswires) -- Sarepta Therapeutics ( SRPT ) said Monday that the second part of a phase 3 clinical study of the gene therapy Elevidys for the potential treatment of Duchenne muscular dystrophy has yielded positive topline results. Patients treated with a placebo in the first part of the study but began receiving the drug, also...
US Steel Investor Ancora Reportedly Seeks End of Nippon Merger, CEO Replacement
US Steel Investor Ancora Reportedly Seeks End of Nippon Merger, CEO Replacement
Jan 27, 2025
04:59 AM EST, 01/27/2025 (MT Newswires) -- US Steel (X) investor Ancora Holdings is pushing the company to stop pursuing a merger with Nippon Steel and has also nominated nine directors to US Steel's board, multiple media outlets reported Sunday, citing sources familiar with the matter. The activist investor is calling for the ouster of US Steel CEO David Burritt...
Copyright 2023-2026 - www.financetom.com All Rights Reserved